Gardner Lewis Asset Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Gardner Lewis Asset Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-298,160	Closed	-$15.4M	–	88
2022 Q3	$15.4M	Buy	+298,160	New	+$12.3M	3.39%	7

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Gardner Lewis Asset Management's CCXI Position: Q4 2022 in Review

Gardner Lewis Asset Management sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 298,160 shares — an estimated $15.4M sold.

Gardner Lewis Asset Management first reported a position in CCXI in Q3 2022 and held it in 1 quarter. The position peaked at $15.4M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Gardner Lewis Asset Management reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Gardner Lewis Asset Management sold 298,160 ChemoCentryx, Inc. shares in Q4 2022, an estimated $15.4M.
Gardner Lewis Asset Management first reported a position in ChemoCentryx, Inc. in Q3 2022 and held it in 1 quarter.
Gardner Lewis Asset Management's ChemoCentryx, Inc. position peaked at $15.4M in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Gardner Lewis Asset Management's 13F filing for Q4 2022, filed 10 Feb 2023.